LINEZOLID INJECTION DIN 02539748
Health Canada record
| Active ingredient(s) | LINEZOLID 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01XX08 LINEZOLID |
| Original market date | 16-Jun-2026 |
| Current status date | 16-Jun-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eugia Pharma Inc. — licence 3-002768, currently licensed, last inspection rating C (2026-02-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LINEZOLID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02426552 | APO-LINEZOLID | APOTEX INC | Tablet | LINEZOLID 600 MG | Marketed |
| 02520354 | JAMP LINEZOLID | JAMP PHARMA CORPORATION | Tablet | LINEZOLID 600 MG | Marketed |
| 02430827 | LINEZOLID INJECTION | FRESENIUS KABI CANADA LTD | Solution | LINEZOLID 2 MG | Marketed |
| 02461897 | LINEZOLID INJECTION | PHARMARIS CANADA INC | Solution | LINEZOLID 2 MG | Approved |
| 02481278 | LINEZOLID INJECTION | JAMP PHARMA CORPORATION | Solution | LINEZOLID 2 MG | Marketed |
| 02469294 | LINEZOLID INJECTION | AURO PHARMA INC | Solution | LINEZOLID 2 MG | Approved |
| 02486156 | LINEZOLID TABLETS | STRIDES PHARMA CANADA INC | Tablet | LINEZOLID 600 MG | Approved |
| 02422689 | SANDOZ LINEZOLID | SANDOZ CANADA INCORPORATED | Tablet | LINEZOLID 600 MG | Marketed |
| 02243686 | ZYVOXAM | PFIZER CANADA ULC | Powder For Suspension | LINEZOLID 100 MG | Marketed |
| 02243685 | ZYVOXAM | PFIZER CANADA ULC | Solution | LINEZOLID 2 MG | Marketed |
| 02457903 | LINEZOLID | PANDA PHARMACEUTICALS INC. | Tablet | LINEZOLID 600 MG | Cancelled Pre Market |
| 02441012 | LINEZOLID INJECTION | HOSPIRA HEALTHCARE ULC | Solution | LINEZOLID 2 MG | Cancelled Pre Market |
| 02402637 | LINEZOLID INJECTION | TEVA CANADA LIMITED | Solution | LINEZOLID 2 MG | Cancelled Post Market |
| 02429527 | LINEZOLID INJECTION | SANDOZ CANADA INCORPORATED | Solution | LINEZOLID 2 MG | Cancelled Pre Market |
| 02462214 | LINEZOLID INJECTION | MDA INC. | Solution | LINEZOLID 2 MG | Cancelled Pre Market |
| 02470551 | LINEZOLID INTRAVENOUS INJECTION | MDA INC. | Solution | LINEZOLID 600 MG | Cancelled Pre Market |
| 02359235 | NOVO-LINEZOLID | TEVA CANADA LIMITED | Tablet | LINEZOLID 600 MG | Cancelled Pre Market |
| 02243684 | ZYVOXAM 600 MG | PFIZER CANADA ULC | Tablet | LINEZOLID 600 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 31243 | 2023-07-19 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement Between Two Manufacturers |
International API supply for LINEZOLID
31 active FDA Drug Master Files.
Request a quote for LINEZOLID INJECTION